Drug Repurposing for the Treatment of Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a heterogeneous disease characterized by the accumulation of immature myeloid progenitor cells in the bone marrow, compromising of normal blood cell production and ultimately resulting in bone marrow failure. With a 20% overall survival rate at 5 years and 50% in the...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Frontiers Media S.A.
2017-11-01
|
| Серии: | Frontiers in Medicine |
| Предметы: | |
| Online-ссылка: | http://journal.frontiersin.org/article/10.3389/fmed.2017.00211/full |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|